Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
By highlighting outcomes like cardiovascular risk reduction, the company hopes to signal that its model is "care, delivered at scale, with data to back it up," rather than hype-driven DTC medicine
GLP-1 drugs were originally developed decades ago as diabetes treatments that alter the hormonal makeup of the brain and gut reducing hunger and slowing digestion
Insulin resistance, thyroid dysfunction, polycystic ovary syndrome (PCOS), medication side effects, and sleep disorders can all produce similar clinical pictures
In 2023, the Biden administration moved 19 research peptides to category 2 on numerous risks like immunogenicity, manufacturing impurities and a lack of robust human clinical trial data and significant safety concerns. A 2025 University of Utah study published in the National Library of Medicine said one peptide on the list could theoretically catalyze tumor growth
It's after you're coming out of an overnight fast
US$ 21.79
US$ 25.79
US$ 29.59
US$ 20.58
US$ 25.28
US$ 24.81
US$ 24.21
US$ 26.65
US$ 22.46
